Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients. - Santini,D.; Vincenzi,B.; Galluzzo,S. (Clin Cancer Res, 2007)